PRESTRELSKI STEVEN
Insider CIK 1744027 · XERS See Remarks · XERS Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings, | A Award | 2023-01-31 | 2023-02-01 | 150,000 | — | $0 | 719,780 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2022-02-22 | 2022-02-24 | 11,228 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2022-02-22 | 2022-02-24 | 11,228 | $2.42 | $27.2K | 569,780 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2022-02-22 | 2022-02-24 | 11,228 | $0.69 | $7.7K | 581,008 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2022-01-03 | 2022-01-05 | 75,000 | — | $0 | 569,780 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 14,036 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 11,228 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 25,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 25,000 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 11,266 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer deriv | 2021-10-05 | 2021-10-05 | 28,072 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 11,228 | — | $0 | 11,228 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 28,072 | — | $0 | 28,072 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 11,266 | — | $0 | 11,266 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 14,036 | — | $0 | 14,036 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 384,780 | — | $0 | 110,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | D To issuer | 2021-10-05 | 2021-10-05 | 110,000 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 110,000 | — | $0 | 494,780 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 384,780 | — | $0 | 384,780 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2021-04-12 | 2021-04-13 | 10,000 | $4.07 | $40.7K | 496,824 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2021-01-29 | 2021-02-01 | 100,000 | — | $0 | 506,824 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2021-01-13 | 2021-01-15 | 10,000 | $6.01 | $60.1K | 406,824 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2021-01-11 | 2021-01-12 | 10,000 | $5.72 | $57.2K | 416,824 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | G Gift | 2020-12-16 | 2020-12-17 | 10,000 | — | $0 | 426,824 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2020-08-14 | 2020-08-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award | 2020-01-31 | 2020-03-02 | 15,000 | — | $0 | 436,824 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2020-01-13 | 2020-01-14 | 10,000 | $5.50 | $55.0K | 421,824 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | G Gift | 2019-11-19 | 2019-11-20 | 17,500 | — | $0 | 431,824 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-10-11 | 2019-10-16 | 10,000 | $7.97 | $79.7K | 449,324 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-07-11 | 2019-10-16 | 9,962 | $12.04 | $119.9K | 459,362 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-07-11 | 2019-10-16 | 38 | $12.70 | $483 | 459,324 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-04-11 | 2019-04-12 | 10,000 | $9.56 | $95.6K | 477,024 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | A Award deriv | 2019-01-31 | 2019-02-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-14 | 2019-10-16 | 7,700 | $17.20 | $132.4K | 469,324 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2019-01-11 | 2019-01-15 | 2,300 | — | $0 | 487,024 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | S Sale | 2018-12-26 | 2019-01-02 | 15,720 | $15.82 | $248.7K | 489,324 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | M Exercise deriv | 2018-12-24 | 2019-01-02 | 15,720 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | M Exercise | 2018-12-24 | 2019-01-02 | 15,720 | $1.19 | $18.7K | 505,044 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion deriv | 2018-06-25 | 2018-06-27 | 12,701 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion deriv | 2018-06-25 | 2018-06-27 | 53,849 | — | $0 | 0 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion | 2018-06-25 | 2018-06-27 | 30,232 | — | $0 | 482,193 | SEC↗ |
| XERS XERIS PHARMACEUTICALS INC | C Conversion | 2018-06-25 | 2018-06-27 | 7,130 | — | $0 | 489,323 | SEC↗ |